Research: Women to gain from new cancer treatment

WA women with endometrial cancer are taking part in the Australian trial of a treatment that can delay the need for radical surgery. Endometrial cancer is the most common gynaecological cancer and is diagnosed in 2400 Australian women each year. The standard treatment is a total hysterectomy as well as removing ovaries and fallopian tubes. Gynaecologists at King Edward Memorial Hospital have been recruiting women into the Femme study, looking at treatment combinations, including a hormone-releasing intra-uterine device, the diabetes drug metformin and a weight loss program. Doctors believe this alternative treatment can safely allow women to delay surgery without jeopardising their cancer outcome. The West Australian, 20 July 2017, page 18

#Treatment #Research #EndometrialCancer #Cancer #WesternAustralia #Australia #Trials